The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"Blc2-like
".
FunFam 4: apoptosis regulator BAX isoform X2
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 29 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Lipid binding GO:0008289
Interacting selectively and non-covalently with a lipid.
|
37 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(27 more) |
Channel activity GO:0015267
Enables the energy-independent facilitated diffusion, mediated by passage of a solute through a transmembrane aqueous pore or channel. Stereospecificity is not exhibited but this transport may be specific for a particular molecular species or class of molecules.
|
37 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(27 more) |
BH3 domain binding GO:0051434
Interacting selectively and non-covalently with the BH3 domain of a protein of the Bcl-2 family. The BH3 domain is a potent death domain and has an important role in protein-protein interactions and in cell death.
|
35 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(25 more) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
7 | Q07812 (/IPI) Q07812 (/IPI) Q07812 (/IPI) Q07812 (/IPI) Q07813 (/IPI) Q07813 (/IPI) Q63690 (/IPI) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
7 | Q07812 (/IPI) Q07812 (/IPI) Q07812 (/IPI) Q07812 (/IPI) Q07813 (/IPI) Q07813 (/IPI) Q63690 (/IPI) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
6 | Q07812 (/IPI) Q07812 (/IPI) Q07812 (/IPI) Q07812 (/IPI) Q07813 (/IPI) Q07813 (/IPI) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
6 | O02703 (/ISS) O02703 (/ISS) O02703 (/ISS) Q8HYU5 (/ISS) Q8HYU5 (/ISS) Q8SQ43 (/ISS) |
Lipid binding GO:0008289
Interacting selectively and non-covalently with a lipid.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Channel activity GO:0015267
Enables the energy-independent facilitated diffusion, mediated by passage of a solute through a transmembrane aqueous pore or channel. Stereospecificity is not exhibited but this transport may be specific for a particular molecular species or class of molecules.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
4 | Q07812 (/IPI) Q07812 (/IPI) Q07812 (/IPI) Q07812 (/IPI) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
BH3 domain binding GO:0051434
Interacting selectively and non-covalently with the BH3 domain of a protein of the Bcl-2 family. The BH3 domain is a potent death domain and has an important role in protein-protein interactions and in cell death.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
BH3 domain binding GO:0051434
Interacting selectively and non-covalently with the BH3 domain of a protein of the Bcl-2 family. The BH3 domain is a potent death domain and has an important role in protein-protein interactions and in cell death.
|
4 | Q07812 (/IPI) Q07812 (/IPI) Q07812 (/IPI) Q07812 (/IPI) |
Chaperone binding GO:0051087
Interacting selectively and non-covalently with a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport.
|
3 | Q07813 (/IPI) Q07813 (/IPI) Q63690 (/IPI) |
Lipid binding GO:0008289
Interacting selectively and non-covalently with a lipid.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Channel activity GO:0015267
Enables the energy-independent facilitated diffusion, mediated by passage of a solute through a transmembrane aqueous pore or channel. Stereospecificity is not exhibited but this transport may be specific for a particular molecular species or class of molecules.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Hsp70 protein binding GO:0030544
Interacting selectively and non-covalently with Hsp70 proteins, any of a group of heat shock proteins around 70kDa in size.
|
2 | Q07813 (/IDA) Q07813 (/IDA) |
Heat shock protein binding GO:0031072
Interacting selectively and non-covalently with a heat shock protein, any protein synthesized or activated in response to heat shock.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Protein-containing complex binding GO:0044877
Interacting selectively and non-covalently with a macromolecular complex.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Chaperone binding GO:0051087
Interacting selectively and non-covalently with a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
BH domain binding GO:0051400
Interacting selectively and non-covalently with the Bcl-2 homology (BH) domain of a protein. Bcl-2-related proteins share homology in one to four conserved regions designated the Bcl-2 homology (BH) domains BH1, BH2, BH3 and BH4. These domains contribute at multiple levels to the function of these proteins in cell death and survival. Anti-apoptotic members of the Bcl-2 family have four BH domains (BH1-BH4). Pro-apoptotic members have fewer BH domains.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
BH3 domain binding GO:0051434
Interacting selectively and non-covalently with the BH3 domain of a protein of the Bcl-2 family. The BH3 domain is a potent death domain and has an important role in protein-protein interactions and in cell death.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Heat shock protein binding GO:0031072
Interacting selectively and non-covalently with a heat shock protein, any protein synthesized or activated in response to heat shock.
|
1 | Q63690 (/IPI) |
Protein-containing complex binding GO:0044877
Interacting selectively and non-covalently with a macromolecular complex.
|
1 | Q63690 (/IPI) |
BH domain binding GO:0051400
Interacting selectively and non-covalently with the Bcl-2 homology (BH) domain of a protein. Bcl-2-related proteins share homology in one to four conserved regions designated the Bcl-2 homology (BH) domains BH1, BH2, BH3 and BH4. These domains contribute at multiple levels to the function of these proteins in cell death and survival. Anti-apoptotic members of the Bcl-2 family have four BH domains (BH1-BH4). Pro-apoptotic members have fewer BH domains.
|
1 | Q63690 (/IPI) |
There are 210 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Mitochondrial fusion GO:0008053
Merging of two or more mitochondria within a cell to form a single compartment.
|
37 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(27 more) |
Establishment or maintenance of transmembrane electrochemical gradient GO:0010248
The directed movement of ions to establish or maintain an electrochemical gradient across a membrane by means of some agent such as a transporter or pore.
|
37 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(27 more) |
Negative regulation of protein binding GO:0032091
Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.
|
37 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(27 more) |
Positive regulation of protein oligomerization GO:0032461
Any process that activates or increases the frequency, rate or extent of protein oligomerization.
|
37 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(27 more) |
Release of matrix enzymes from mitochondria GO:0032976
The process in which enzymes, such as aspartate aminotransferase, are enabled to move from the mitochondrial matrix into the cytosol, as part of the apoptotic process.
|
37 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(27 more) |
Regulation of protein homodimerization activity GO:0043496
Any process that modulates the frequency, rate or extent of protein homodimerization, interacting selectively with an identical protein to form a homodimer.
|
37 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(27 more) |
Mitochondrial fragmentation involved in apoptotic process GO:0043653
The change in the morphology of the mitochondria in an apoptotic cell from a highly branched network to a fragmented vesicular form.
|
37 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(27 more) |
Positive regulation of release of cytochrome c from mitochondria GO:0090200
Any process that increases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.
|
37 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(27 more) |
Positive regulation of endoplasmic reticulum unfolded protein response GO:1900103
Any process that activates or increases the frequency, rate or extent of endoplasmic reticulum unfolded protein response.
|
37 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(27 more) |
Positive regulation of intrinsic apoptotic signaling pathway GO:2001244
Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway.
|
37 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(27 more) |
B cell apoptotic process GO:0001783
Any apoptotic process in a B cell, a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity.
|
35 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(25 more) |
Activation of cysteine-type endopeptidase activity involved in apoptotic process GO:0006919
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process.
|
35 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(25 more) |
Activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c GO:0008635
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process and is mediated by cytochrome c.
|
35 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(25 more) |
Apoptotic mitochondrial changes GO:0008637
The morphological and physiological alterations undergone by mitochondria during apoptosis.
|
35 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(25 more) |
Response to toxic substance GO:0009636
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus.
|
35 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(25 more) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
35 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(25 more) |
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
|
35 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(25 more) |
Regulation of mitochondrial membrane potential GO:0051881
Any process that modulates the establishment or extent of the mitochondrial membrane potential, the electric potential existing across the mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
|
35 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(25 more) |
Intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress GO:0070059
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to a stimulus indicating endoplasmic reticulum (ER) stress, and ends when the execution phase of apoptosis is triggered. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.
|
35 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(25 more) |
Apoptotic signaling pathway GO:0097190
A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered.
|
35 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(25 more) |
Intrinsic apoptotic signaling pathway GO:0097193
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway starts with reception of an intracellular signal (e.g. DNA damage, endoplasmic reticulum stress, oxidative stress etc.), and ends when the execution phase of apoptosis is triggered. The intrinsic apoptotic signaling pathway is crucially regulated by permeabilization of the mitochondrial outer membrane (MOMP).
|
35 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(25 more) |
Release of cytochrome c from mitochondria GO:0001836
The process that results in the movement of cytochrome c from the mitochondrial intermembrane space into the cytosol, which is part of the apoptotic signaling pathway and leads to caspase activation.
|
34 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(24 more) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
8 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07813 (/IDA) Q07813 (/IDA) Q63690 (/IDA) Q9I9N4 (/IDA) |
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
|
7 | Q07812 (/IMP) Q07812 (/IMP) Q07812 (/IMP) Q07812 (/IMP) Q07813 (/IMP) Q07813 (/IMP) Q63690 (/IMP) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
7 | Q07812 (/IMP) Q07812 (/IMP) Q07812 (/IMP) Q07812 (/IMP) Q07813 (/IMP) Q07813 (/IMP) Q63690 (/IMP) |
Release of cytochrome c from mitochondria GO:0001836
The process that results in the movement of cytochrome c from the mitochondrial intermembrane space into the cytosol, which is part of the apoptotic signaling pathway and leads to caspase activation.
|
6 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07813 (/IDA) Q07813 (/IDA) |
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
|
6 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07813 (/IDA) Q07813 (/IDA) |
Activation of cysteine-type endopeptidase activity involved in apoptotic process GO:0006919
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process.
|
6 | Q07812 (/IMP) Q07812 (/IMP) Q07812 (/IMP) Q07812 (/IMP) Q07813 (/IMP) Q07813 (/IMP) |
Activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c GO:0008635
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process and is mediated by cytochrome c.
|
6 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07813 (/IDA) Q07813 (/IDA) |
Apoptotic mitochondrial changes GO:0008637
The morphological and physiological alterations undergone by mitochondria during apoptosis.
|
6 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07813 (/IDA) Q07813 (/IDA) |
Negative regulation of mitochondrial membrane potential GO:0010917
Any process that stops, prevents, or reduces the frequency, rate or extent of establishment or extent of a mitochondrial membrane potential, the electric potential existing across any mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
|
6 | O02703 (/ISS) O02703 (/ISS) O02703 (/ISS) Q07813 (/ISS) Q07813 (/ISS) Q63690 (/ISS) |
Protein homooligomerization GO:0051260
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of identical component monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
|
6 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07813 (/IDA) Q07813 (/IDA) |
Protein homooligomerization GO:0051260
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of identical component monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
|
6 | O02703 (/ISS) O02703 (/ISS) O02703 (/ISS) Q8HYU5 (/ISS) Q8HYU5 (/ISS) Q8SQ43 (/ISS) |
Positive regulation of intrinsic apoptotic signaling pathway GO:2001244
Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway.
|
6 | Q07812 (/IMP) Q07812 (/IMP) Q07812 (/IMP) Q07812 (/IMP) Q07813 (/IMP) Q07813 (/IMP) |
B cell apoptotic process GO:0001783
Any apoptotic process in a B cell, a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Protein insertion into mitochondrial membrane involved in apoptotic signaling pathway GO:0001844
The process in which a protein is incorporated into a mitochondrial membrane as the initial phase of the mitochondrial membrane permeabilization that takes place in the apoptotic signaling pathway.
|
4 | Q07812 (/TAS) Q07812 (/TAS) Q07812 (/TAS) Q07812 (/TAS) |
Transcription initiation from RNA polymerase II promoter GO:0006367
Any process involved in the assembly of the RNA polymerase II preinitiation complex (PIC) at an RNA polymerase II promoter region of a DNA template, resulting in the subsequent synthesis of RNA from that promoter. The initiation phase includes PIC assembly and the formation of the first few bonds in the RNA chain, including abortive initiation, which occurs when the first few nucleotides are repeatedly synthesized and then released. Promoter clearance, or release, is the transition between the initiation and elongation phases of transcription.
|
4 | Q07812 (/TAS) Q07812 (/TAS) Q07812 (/TAS) Q07812 (/TAS) |
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
|
4 | Q07812 (/NAS) Q07812 (/NAS) Q07812 (/NAS) Q07812 (/NAS) |
Activation of cysteine-type endopeptidase activity involved in apoptotic process GO:0006919
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest GO:0006977
A cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage and resulting in the stopping or reduction in rate of the cell cycle.
|
4 | Q07812 (/TAS) Q07812 (/TAS) Q07812 (/TAS) Q07812 (/TAS) |
Mitochondrial fusion GO:0008053
Merging of two or more mitochondria within a cell to form a single compartment.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Extrinsic apoptotic signaling pathway via death domain receptors GO:0008625
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with a ligand binding to a death domain receptor on the cell surface, and ends when the execution phase of apoptosis is triggered.
|
4 | Q07812 (/IC) Q07812 (/IC) Q07812 (/IC) Q07812 (/IC) |
Response to toxic substance GO:0009636
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Establishment or maintenance of transmembrane electrochemical gradient GO:0010248
The directed movement of ions to establish or maintain an electrochemical gradient across a membrane by means of some agent such as a transporter or pore.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Negative regulation of mitochondrial membrane potential GO:0010917
Any process that stops, prevents, or reduces the frequency, rate or extent of establishment or extent of a mitochondrial membrane potential, the electric potential existing across any mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Negative regulation of protein binding GO:0032091
Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Positive regulation of protein oligomerization GO:0032461
Any process that activates or increases the frequency, rate or extent of protein oligomerization.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Endoplasmic reticulum calcium ion homeostasis GO:0032469
Any process involved in the maintenance of an internal steady state of calcium ions within the endoplasmic reticulum of a cell or between the endoplasmic reticulum and its surroundings.
|
4 | Q07812 (/TAS) Q07812 (/TAS) Q07812 (/TAS) Q07812 (/TAS) |
Release of matrix enzymes from mitochondria GO:0032976
The process in which enzymes, such as aspartate aminotransferase, are enabled to move from the mitochondrial matrix into the cytosol, as part of the apoptotic process.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Cellular response to unfolded protein GO:0034620
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an unfolded protein stimulus.
|
4 | Q07812 (/TAS) Q07812 (/TAS) Q07812 (/TAS) Q07812 (/TAS) |
Regulation of apoptotic process GO:0042981
Any process that modulates the occurrence or rate of cell death by apoptotic process.
|
4 | Q07812 (/TAS) Q07812 (/TAS) Q07812 (/TAS) Q07812 (/TAS) |
Regulation of protein homodimerization activity GO:0043496
Any process that modulates the frequency, rate or extent of protein homodimerization, interacting selectively with an identical protein to form a homodimer.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Regulation of protein heterodimerization activity GO:0043497
Any process that modulates the frequency, rate or extent of protein heterodimerization, interacting selectively with a nonidentical protein to form a heterodimer.
|
4 | Q07812 (/IPI) Q07812 (/IPI) Q07812 (/IPI) Q07812 (/IPI) |
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Mitochondrial fragmentation involved in apoptotic process GO:0043653
The change in the morphology of the mitochondria in an apoptotic cell from a highly branched network to a fragmented vesicular form.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Protein complex oligomerization GO:0051259
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers; protein oligomers may be composed of different or identical monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Regulation of mitochondrial membrane potential GO:0051881
Any process that modulates the establishment or extent of the mitochondrial membrane potential, the electric potential existing across the mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress GO:0070059
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to a stimulus indicating endoplasmic reticulum (ER) stress, and ends when the execution phase of apoptosis is triggered. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.
|
4 | Q07812 (/IMP) Q07812 (/IMP) Q07812 (/IMP) Q07812 (/IMP) |
Intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress GO:0070059
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to a stimulus indicating endoplasmic reticulum (ER) stress, and ends when the execution phase of apoptosis is triggered. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.
|
4 | Q07812 (/TAS) Q07812 (/TAS) Q07812 (/TAS) Q07812 (/TAS) |
Positive regulation of release of cytochrome c from mitochondria GO:0090200
Any process that increases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Positive regulation of release of cytochrome c from mitochondria GO:0090200
Any process that increases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.
|
4 | Q07812 (/IMP) Q07812 (/IMP) Q07812 (/IMP) Q07812 (/IMP) |
Apoptotic signaling pathway GO:0097190
A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Extrinsic apoptotic signaling pathway GO:0097191
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Intrinsic apoptotic signaling pathway GO:0097193
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway starts with reception of an intracellular signal (e.g. DNA damage, endoplasmic reticulum stress, oxidative stress etc.), and ends when the execution phase of apoptosis is triggered. The intrinsic apoptotic signaling pathway is crucially regulated by permeabilization of the mitochondrial outer membrane (MOMP).
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Positive regulation of endoplasmic reticulum unfolded protein response GO:1900103
Any process that activates or increases the frequency, rate or extent of endoplasmic reticulum unfolded protein response.
|
4 | Q07812 (/IMP) Q07812 (/IMP) Q07812 (/IMP) Q07812 (/IMP) |
Positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway GO:1901030
Any process that activates or increases the frequency, rate or extent of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway.
|
4 | Q07812 (/TAS) Q07812 (/TAS) Q07812 (/TAS) Q07812 (/TAS) |
Positive regulation of apoptotic DNA fragmentation GO:1902512
Any process that activates or increases the frequency, rate or extent of apoptotic DNA fragmentation.
|
4 | Q07812 (/IMP) Q07812 (/IMP) Q07812 (/IMP) Q07812 (/IMP) |
Positive regulation of IRE1-mediated unfolded protein response GO:1903896
Any process that activates or increases the frequency, rate or extent of the IRE1-mediated unfolded protein response.
|
4 | Q07812 (/TAS) Q07812 (/TAS) Q07812 (/TAS) Q07812 (/TAS) |
B cell receptor apoptotic signaling pathway GO:1990117
An extrinsic apoptotic signaling pathway initiated by the cross-linking of an antigen receptor on a B cell.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Ovarian follicle development GO:0001541
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Ovarian follicle development GO:0001541
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Neuron migration GO:0001764
The characteristic movement of an immature neuron from germinal zones to specific positions where they will reside as they mature.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Leukocyte homeostasis GO:0001776
The process of regulating the proliferation and elimination of cells of the immune system such that the total number of cells of a particular cell type within a whole or part of an organism is stable over time in the absence of an outside stimulus.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
T cell homeostatic proliferation GO:0001777
The non-specific expansion of T cell populations within a whole or part of an organism to reach to a total number of T cells which will then remain stable over time in the absence of an external stimulus.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
B cell homeostasis GO:0001782
The process of regulating the proliferation and elimination of B cells such that the total number of B cells within a whole or part of an organism is stable over time in the absence of an outside stimulus.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
B cell homeostasis GO:0001782
The process of regulating the proliferation and elimination of B cells such that the total number of B cells within a whole or part of an organism is stable over time in the absence of an outside stimulus.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
B cell apoptotic process GO:0001783
Any apoptotic process in a B cell, a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
B cell apoptotic process GO:0001783
Any apoptotic process in a B cell, a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Release of cytochrome c from mitochondria GO:0001836
The process that results in the movement of cytochrome c from the mitochondrial intermembrane space into the cytosol, which is part of the apoptotic signaling pathway and leads to caspase activation.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Release of cytochrome c from mitochondria GO:0001836
The process that results in the movement of cytochrome c from the mitochondrial intermembrane space into the cytosol, which is part of the apoptotic signaling pathway and leads to caspase activation.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Protein insertion into mitochondrial membrane involved in apoptotic signaling pathway GO:0001844
The process in which a protein is incorporated into a mitochondrial membrane as the initial phase of the mitochondrial membrane permeabilization that takes place in the apoptotic signaling pathway.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Blood vessel remodeling GO:0001974
The reorganization or renovation of existing blood vessels.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Myeloid cell homeostasis GO:0002262
The process of regulating the proliferation and elimination of myeloid cells such that the total number of myeloid cells within a whole or part of an organism is stable over time in the absence of an outside stimulus.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
B cell negative selection GO:0002352
Any process leading to negative selection in B cells. Mechanisms of negative selection include anergy and deletion.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
B cell homeostatic proliferation GO:0002358
The non-specific expansion of B cell populations within a whole or part of an organism to reach to a total number of B cells which will then remain stable over time in the absence of an external stimulus.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Positive regulation of B cell apoptotic process GO:0002904
Any process that activates or increases the frequency, rate, or extent of B cell apoptotic process.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Glycosphingolipid metabolic process GO:0006687
The chemical reactions and pathways involving glycosphingolipids, any compound with residues of sphingoid and at least one monosaccharide.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Regulation of nitrogen utilization GO:0006808
Any process that modulates the frequency, rate or extent of nitrogen utilization.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Activation of cysteine-type endopeptidase activity involved in apoptotic process GO:0006919
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Activation of cysteine-type endopeptidase activity involved in apoptotic process GO:0006919
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Cellular response to DNA damage stimulus GO:0006974
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Inner mitochondrial membrane organization GO:0007007
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the mitochondrial inner membrane.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Outer mitochondrial membrane organization GO:0007008
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the mitochondrial outer membrane.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Germ cell development GO:0007281
The process whose specific outcome is the progression of an immature germ cell over time, from its formation to the mature structure (gamete). A germ cell is any reproductive cell in a multicellular organism.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Spermatogenesis GO:0007283
The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Spermatogenesis GO:0007283
The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Nervous system development GO:0007399
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Sex differentiation GO:0007548
The establishment of the sex of an organism by physical differentiation.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Mitochondrial fusion GO:0008053
Merging of two or more mitochondria within a cell to form a single compartment.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Mitochondrial fusion GO:0008053
Merging of two or more mitochondria within a cell to form a single compartment.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
2 | Q07813 (/IDA) Q07813 (/IDA) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Extrinsic apoptotic signaling pathway via death domain receptors GO:0008625
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with a ligand binding to a death domain receptor on the cell surface, and ends when the execution phase of apoptosis is triggered.
|
2 | Q07813 (/IDA) Q07813 (/IDA) |
Intrinsic apoptotic signaling pathway in response to DNA damage GO:0008630
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced by the detection of DNA damage, and ends when the execution phase of apoptosis is triggered.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Intrinsic apoptotic signaling pathway in response to DNA damage GO:0008630
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced by the detection of DNA damage, and ends when the execution phase of apoptosis is triggered.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c GO:0008635
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process and is mediated by cytochrome c.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c GO:0008635
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process and is mediated by cytochrome c.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Apoptotic mitochondrial changes GO:0008637
The morphological and physiological alterations undergone by mitochondria during apoptosis.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Fertilization GO:0009566
The union of gametes of opposite sexes during the process of sexual reproduction to form a zygote. It involves the fusion of the gametic nuclei (karyogamy) and cytoplasm (plasmogamy).
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Response to wounding GO:0009611
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Response to toxic substance GO:0009636
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Response to toxic substance GO:0009636
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Response to salt stress GO:0009651
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating an increase or decrease in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Post-embryonic development GO:0009791
The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Response to ionizing radiation GO:0010212
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ionizing radiation stimulus. Ionizing radiation is radiation with sufficient energy to remove electrons from atoms and may arise from spontaneous decay of unstable isotopes, resulting in alpha and beta particles and gamma rays. Ionizing radiation also includes X-rays.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Response to ionizing radiation GO:0010212
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ionizing radiation stimulus. Ionizing radiation is radiation with sufficient energy to remove electrons from atoms and may arise from spontaneous decay of unstable isotopes, resulting in alpha and beta particles and gamma rays. Ionizing radiation also includes X-rays.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Establishment or maintenance of transmembrane electrochemical gradient GO:0010248
The directed movement of ions to establish or maintain an electrochemical gradient across a membrane by means of some agent such as a transporter or pore.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Response to gamma radiation GO:0010332
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gamma radiation stimulus. Gamma radiation is a form of electromagnetic radiation (EMR) or light emission of a specific frequency produced from sub-atomic particle interaction, such as electron-positron annihilation and radioactive decay. Gamma rays are generally characterized as EMR having the highest frequency and energy, and also the shortest wavelength, within the electromagnetic radiation spectrum.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Positive regulation of calcium ion transport into cytosol GO:0010524
Any process that increases the rate of the directed movement of calcium ions into the cytosol of a cell. The cytosol is that part of the cytoplasm that does not contain membranous or particulate subcellular components.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Negative regulation of mitochondrial membrane potential GO:0010917
Any process that stops, prevents, or reduces the frequency, rate or extent of establishment or extent of a mitochondrial membrane potential, the electric potential existing across any mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Hypothalamus development GO:0021854
The progression of the hypothalamus region of the forebrain, from its initial formation to its mature state.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Cerebral cortex development GO:0021987
The progression of the cerebral cortex over time from its initial formation until its mature state. The cerebral cortex is the outer layered region of the telencephalon.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Negative regulation of protein binding GO:0032091
Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Positive regulation of protein oligomerization GO:0032461
Any process that activates or increases the frequency, rate or extent of protein oligomerization.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Negative regulation of endoplasmic reticulum calcium ion concentration GO:0032471
Any process that decreases the concentration of calcium ions in the endoplasmic reticulum.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Release of matrix enzymes from mitochondria GO:0032976
The process in which enzymes, such as aspartate aminotransferase, are enabled to move from the mitochondrial matrix into the cytosol, as part of the apoptotic process.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Negative regulation of peptidyl-serine phosphorylation GO:0033137
Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Regulation of mammary gland epithelial cell proliferation GO:0033599
Any process that modulates the frequency, rate or extent of mammary gland epithelial cell proliferation.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Cellular response to UV GO:0034644
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Limb morphogenesis GO:0035108
The process in which the anatomical structures of a limb are generated and organized. A limb is a paired appendage of a tetrapod used for locomotion or grasping.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Ectopic germ cell programmed cell death GO:0035234
Programmed cell death of an errant germ line cell that is outside the normal migratory path or ectopic to the gonad. This is an important mechanism of regulating germ cell survival within the embryo.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Ectopic germ cell programmed cell death GO:0035234
Programmed cell death of an errant germ line cell that is outside the normal migratory path or ectopic to the gonad. This is an important mechanism of regulating germ cell survival within the embryo.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Odontogenesis of dentin-containing tooth GO:0042475
The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043281
Any process that modulates the activity of a cysteine-type endopeptidase involved in apoptosis.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Regulation of protein homodimerization activity GO:0043496
Any process that modulates the frequency, rate or extent of protein homodimerization, interacting selectively with an identical protein to form a homodimer.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Regulation of protein heterodimerization activity GO:0043497
Any process that modulates the frequency, rate or extent of protein heterodimerization, interacting selectively with a nonidentical protein to form a heterodimer.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Regulation of neuron apoptotic process GO:0043523
Any process that modulates the occurrence or rate of cell death by apoptotic process in neurons.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Negative regulation of neuron apoptotic process GO:0043524
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
|
2 | Q07813 (/IDA) Q07813 (/IDA) |
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Mitochondrial fragmentation involved in apoptotic process GO:0043653
The change in the morphology of the mitochondria in an apoptotic cell from a highly branched network to a fragmented vesicular form.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Development of secondary sexual characteristics GO:0045136
The process whose specific outcome is the progression of the secondary sexual characteristics over time, from their formation to the mature structures. In humans, these include growth of axillary, chest, and pubic hair, voice changes, testicular/penile enlargement, breast development and menstrual periods. Development occurs in response to sex hormone secretion.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Cellular respiration GO:0045333
The enzymatic release of energy from inorganic and organic compounds (especially carbohydrates and fats) which either requires oxygen (aerobic respiration) or does not (anaerobic respiration).
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Retinal cell programmed cell death GO:0046666
Programmed cell death that occurs in the developing retina.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Positive regulation of developmental pigmentation GO:0048087
Any process that increases the frequency, rate or extent of the developmental process that results in the deposition of coloring matter in an organism.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Negative regulation of fibroblast proliferation GO:0048147
Any process that stops, prevents, or reduces the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Spermatid differentiation GO:0048515
The process whose specific outcome is the progression of a spermatid over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Post-embryonic camera-type eye morphogenesis GO:0048597
The process in which the anatomical structures of the eye are generated and organized during post-embryonic development.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Response to axon injury GO:0048678
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an axon injury stimulus.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Homeostasis of number of cells GO:0048872
Any biological process involved in the maintenance of the steady-state number of cells within a population of cells.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Homeostasis of number of cells GO:0048872
Any biological process involved in the maintenance of the steady-state number of cells within a population of cells.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Homeostasis of number of cells within a tissue GO:0048873
Any biological process involved in the maintenance of the steady-state number of cells within a population of cells in a tissue.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Protein complex oligomerization GO:0051259
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers; protein oligomers may be composed of different or identical monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Protein homooligomerization GO:0051260
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of identical component monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Positive regulation of release of sequestered calcium ion into cytosol GO:0051281
Any process that activates or increases the frequency, rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Neuron apoptotic process GO:0051402
Any apoptotic process in a neuron, the basic cellular unit of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Neuron apoptotic process GO:0051402
Any apoptotic process in a neuron, the basic cellular unit of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Regulation of cell cycle GO:0051726
Any process that modulates the rate or extent of progression through the cell cycle.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Sertoli cell proliferation GO:0060011
The multiplication or reproduction of Sertoli cells, resulting in the expansion of the Sertoli cell population. A Sertoli cell is a supporting cell projecting inward from the basement membrane of seminiferous tubules.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Retina development in camera-type eye GO:0060041
The process whose specific outcome is the progression of the retina over time, from its formation to the mature structure. The retina is the innermost layer or coating at the back of the eyeball, which is sensitive to light and in which the optic nerve terminates.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Positive regulation of apoptotic process involved in mammary gland involution GO:0060058
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process of mammary epithelial cells during mammary gland involution.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Vagina development GO:0060068
The reproductive developmental process whose specific outcome is the progression of the vagina over time, from its formation to the mature structure.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress GO:0070059
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to a stimulus indicating endoplasmic reticulum (ER) stress, and ends when the execution phase of apoptosis is triggered. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress GO:0070059
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced in response to a stimulus indicating endoplasmic reticulum (ER) stress, and ends when the execution phase of apoptosis is triggered. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Thymocyte apoptotic process GO:0070242
Any apoptotic process in a thymocyte, an immature T cell located in the thymus.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Mitochondrion morphogenesis GO:0070584
The process in which the anatomical structures of a mitochondrion are generated and organized.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Cellular response to organic substance GO:0071310
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
|
2 | Q07813 (/IDA) Q07813 (/IDA) |
Intrinsic apoptotic signaling pathway by p53 class mediator GO:0072332
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, and ends when the execution phase of apoptosis is triggered.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Positive regulation of release of cytochrome c from mitochondria GO:0090200
Any process that increases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Apoptotic signaling pathway GO:0097190
A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Apoptotic signaling pathway GO:0097190
A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Extrinsic apoptotic signaling pathway GO:0097191
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Extrinsic apoptotic signaling pathway in absence of ligand GO:0097192
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with withdrawal of a ligand from a cell surface receptor, and ends when the execution phase of apoptosis is triggered.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Intrinsic apoptotic signaling pathway GO:0097193
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway starts with reception of an intracellular signal (e.g. DNA damage, endoplasmic reticulum stress, oxidative stress etc.), and ends when the execution phase of apoptosis is triggered. The intrinsic apoptotic signaling pathway is crucially regulated by permeabilization of the mitochondrial outer membrane (MOMP).
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway GO:0097296
Any process that initiates the activity of an inactive cysteine-type endopeptidase involved in the apoptotic signaling pathway.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Positive regulation of endoplasmic reticulum unfolded protein response GO:1900103
Any process that activates or increases the frequency, rate or extent of endoplasmic reticulum unfolded protein response.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Regulation of mitochondrial membrane permeability involved in apoptotic process GO:1902108
Any regulation of mitochondrial membrane permeability that is involved in apoptotic process.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Positive regulation of mitochondrial membrane permeability involved in apoptotic process GO:1902110
Any positive regulation of mitochondrial membrane permeability that is involved in apoptotic process.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Apoptotic process involved in blood vessel morphogenesis GO:1902262
Any apoptotic process that is involved in blood vessel morphogenesis.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Apoptotic process involved in embryonic digit morphogenesis GO:1902263
Any apoptotic process that is involved in embryonic digit morphogenesis.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Regulation of mitochondrial membrane permeability involved in programmed necrotic cell death GO:1902445
Any regulation of mitochondrial membrane permeability that is involved in programmed necrotic cell death.
|
2 | Q07813 (/IMP) Q07813 (/IMP) |
Positive regulation of apoptotic DNA fragmentation GO:1902512
Any process that activates or increases the frequency, rate or extent of apoptotic DNA fragmentation.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
B cell receptor apoptotic signaling pathway GO:1990117
An extrinsic apoptotic signaling pathway initiated by the cross-linking of an antigen receptor on a B cell.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Negative regulation of apoptotic signaling pathway GO:2001234
Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic signaling pathway.
|
2 | Q07813 (/IGI) Q07813 (/IGI) |
Positive regulation of intrinsic apoptotic signaling pathway GO:2001244
Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Ovarian follicle development GO:0001541
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
|
1 | Q63690 (/IEP) |
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
|
1 | Q63690 (/IEP) |
Inner mitochondrial membrane organization GO:0007007
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the mitochondrial inner membrane.
|
1 | Q63690 (/IDA) |
Outer mitochondrial membrane organization GO:0007008
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the mitochondrial outer membrane.
|
1 | Q63690 (/IDA) |
Brain development GO:0007420
The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
|
1 | Q63690 (/IEP) |
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
|
1 | Q63690 (/IEP) |
Cerebral cortex development GO:0021987
The progression of the cerebral cortex over time from its initial formation until its mature state. The cerebral cortex is the outer layered region of the telencephalon.
|
1 | Q63690 (/IEP) |
Glial cell apoptotic process GO:0034349
Any apoptotic process in a glial cell, a non-neuronal cell of the nervous system.
|
1 | Q63690 (/IEP) |
Response to cocaine GO:0042220
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cocaine stimulus. Cocaine is a crystalline alkaloid obtained from the leaves of the coca plant.
|
1 | Q63690 (/IEP) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | Q63690 (/IEP) |
Positive regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043280
Any process that activates or increases the activity of a cysteine-type endopeptidase involved in the apoptotic process.
|
1 | Q9I9N4 (/IGI) |
Positive regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043280
Any process that activates or increases the activity of a cysteine-type endopeptidase involved in the apoptotic process.
|
1 | Q9I9N4 (/IMP) |
Cellular respiration GO:0045333
The enzymatic release of energy from inorganic and organic compounds (especially carbohydrates and fats) which either requires oxygen (aerobic respiration) or does not (anaerobic respiration).
|
1 | Q63690 (/IDA) |
Response to cadmium ion GO:0046686
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus.
|
1 | Q9I9N4 (/IEP) |
Response to copper ion GO:0046688
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a copper ion stimulus.
|
1 | Q63690 (/IEP) |
Response to corticosterone GO:0051412
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosterone stimulus. Corticosterone is a 21 carbon steroid hormone of the corticosteroid type, produced in the cortex of the adrenal glands. In many species, corticosterone is the principal glucocorticoid, involved in regulation of fuel metabolism, immune reactions, and stress responses.
|
1 | Q63690 (/IEP) |
Response to methylmercury GO:0051597
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methylmercury stimulus.
|
1 | Q9I9N4 (/IDA) |
There are 47 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
37 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(27 more) |
Mitochondrial permeability transition pore complex GO:0005757
A protein complex that connects the inner and outer membranes of animal mitochondria and acts as a pore that can open transiently to allow free diffusion of solutes between the mitochondrial matrix and the cytosol. The pore complex is formed of the voltage-dependent anion channel (VDAC), the adenine nucleotide translocase (ANT) and cyclophilin-D (CyP-D).
|
37 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(27 more) |
Endoplasmic reticulum membrane GO:0005789
The lipid bilayer surrounding the endoplasmic reticulum.
|
37 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(27 more) |
Pore complex GO:0046930
Any small opening in a membrane that allows the passage of gases and/or liquids.
|
37 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(27 more) |
Bcl-2 family protein complex GO:0097136
A protein complex that consists of members of the Bcl-2 family of anti- and proapoptotic regulators. Bcl-2 proteins respond to cues from various forms of intracellular stress, such as DNA damage or cytokine deprivation, and interact with opposing family members to determine whether or not the caspase proteolytic cascade should be unleashed.
|
37 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(27 more) |
BAX complex GO:0097144
An oligomeric protein complex consisting of BAX, a member of the Bcl-2 family of anti- and proapoptotic regulators.
|
37 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(27 more) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
34 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(24 more) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
34 |
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
F6ZV96 (/ISS)
(24 more) |
Mitochondrial outer membrane GO:0005741
The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.
|
14 |
A0A0D9S330 (/TAS)
A0A0D9S330 (/TAS)
A0A0D9S330 (/TAS)
A0A0D9S330 (/TAS)
A0A0D9S330 (/TAS)
A0A0D9S330 (/TAS)
A0A0D9S330 (/TAS)
A0A0D9S330 (/TAS)
A0A0D9S330 (/TAS)
A0A0D9S330 (/TAS)
(4 more) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
14 |
A0A0D9S330 (/TAS)
A0A0D9S330 (/TAS)
A0A0D9S330 (/TAS)
A0A0D9S330 (/TAS)
A0A0D9S330 (/TAS)
A0A0D9S330 (/TAS)
A0A0D9S330 (/TAS)
A0A0D9S330 (/TAS)
A0A0D9S330 (/TAS)
A0A0D9S330 (/TAS)
(4 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
7 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07813 (/IDA) Q07813 (/IDA) Q63690 (/IDA) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
7 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07813 (/IDA) Q07813 (/IDA) Q63690 (/IDA) |
Mitochondrial outer membrane GO:0005741
The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.
|
7 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07813 (/IDA) Q07813 (/IDA) Q63690 (/IDA) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
7 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07813 (/IDA) Q07813 (/IDA) Q63690 (/IDA) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
6 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07813 (/IDA) Q07813 (/IDA) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
6 | O02703 (/ISS) O02703 (/ISS) O02703 (/ISS) Q8HYU5 (/ISS) Q8HYU5 (/ISS) Q8SQ43 (/ISS) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
4 | Q07812 (/IMP) Q07812 (/IMP) Q07812 (/IMP) Q07812 (/IMP) |
Nuclear envelope GO:0005635
The double lipid bilayer enclosing the nucleus and separating its contents from the rest of the cytoplasm; includes the intermembrane space, a gap of width 20-40 nm (also called the perinuclear space).
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Mitochondrial permeability transition pore complex GO:0005757
A protein complex that connects the inner and outer membranes of animal mitochondria and acts as a pore that can open transiently to allow free diffusion of solutes between the mitochondrial matrix and the cytosol. The pore complex is formed of the voltage-dependent anion channel (VDAC), the adenine nucleotide translocase (ANT) and cyclophilin-D (CyP-D).
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Endoplasmic reticulum membrane GO:0005789
The lipid bilayer surrounding the endoplasmic reticulum.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
4 | Q07812 (/HDA) Q07812 (/HDA) Q07812 (/HDA) Q07812 (/HDA) |
Pore complex GO:0046930
Any small opening in a membrane that allows the passage of gases and/or liquids.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
4 | Q07812 (/HDA) Q07812 (/HDA) Q07812 (/HDA) Q07812 (/HDA) |
Bcl-2 family protein complex GO:0097136
A protein complex that consists of members of the Bcl-2 family of anti- and proapoptotic regulators. Bcl-2 proteins respond to cues from various forms of intracellular stress, such as DNA damage or cytokine deprivation, and interact with opposing family members to determine whether or not the caspase proteolytic cascade should be unleashed.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
BAX complex GO:0097144
An oligomeric protein complex consisting of BAX, a member of the Bcl-2 family of anti- and proapoptotic regulators.
|
4 | Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) Q07812 (/IDA) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
3 | O02703 (/ISS) O02703 (/ISS) O02703 (/ISS) |
Mitochondrial outer membrane GO:0005741
The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.
|
3 | O02703 (/ISS) O02703 (/ISS) O02703 (/ISS) |
Mitochondrial membrane GO:0031966
Either of the lipid bilayers that surround the mitochondrion and form the mitochondrial envelope.
|
3 | Q07813 (/IDA) Q07813 (/IDA) Q63690 (/IDA) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Nuclear envelope GO:0005635
The double lipid bilayer enclosing the nucleus and separating its contents from the rest of the cytoplasm; includes the intermembrane space, a gap of width 20-40 nm (also called the perinuclear space).
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
2 | Q07813 (/HDA) Q07813 (/HDA) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Mitochondrial outer membrane GO:0005741
The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Mitochondrial permeability transition pore complex GO:0005757
A protein complex that connects the inner and outer membranes of animal mitochondria and acts as a pore that can open transiently to allow free diffusion of solutes between the mitochondrial matrix and the cytosol. The pore complex is formed of the voltage-dependent anion channel (VDAC), the adenine nucleotide translocase (ANT) and cyclophilin-D (CyP-D).
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Endoplasmic reticulum membrane GO:0005789
The lipid bilayer surrounding the endoplasmic reticulum.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Integral component of membrane GO:0016021
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
2 | Q07813 (/ISS) Q07813 (/ISS) |
Mitochondrial membrane GO:0031966
Either of the lipid bilayers that surround the mitochondrion and form the mitochondrial envelope.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Pore complex GO:0046930
Any small opening in a membrane that allows the passage of gases and/or liquids.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Bcl-2 family protein complex GO:0097136
A protein complex that consists of members of the Bcl-2 family of anti- and proapoptotic regulators. Bcl-2 proteins respond to cues from various forms of intracellular stress, such as DNA damage or cytokine deprivation, and interact with opposing family members to determine whether or not the caspase proteolytic cascade should be unleashed.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
BAX complex GO:0097144
An oligomeric protein complex consisting of BAX, a member of the Bcl-2 family of anti- and proapoptotic regulators.
|
2 | Q07813 (/IPI) Q07813 (/IPI) |
BAX complex GO:0097144
An oligomeric protein complex consisting of BAX, a member of the Bcl-2 family of anti- and proapoptotic regulators.
|
2 | Q07813 (/ISO) Q07813 (/ISO) |
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
|
1 | Q63690 (/IDA) |